| Literature DB >> 15675608 |
Abstract
GPI-15715 (PQ-1002, Aquavan), a water-soluble prodrug of propofol, is being developed by Guilford, under license from ProQuest, as a potential anesthetic agent. In May 2004, Guilford initiated phase III trials in the US to evaluate the sedative effects of this prodrug in several patient populations.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15675608
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN： 1472-4472